John McMurray
University of Glasgow
H-index: 237
Europe-United Kingdom
Top articles of John McMurray
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Characteristics, management, and outcomes in women and men with congestive heart failure in 40 countries at different economic levels: an analysis from the Global Congestive … | The Lancet Global Health | Marjan Walli-Attaei Philip Joseph Isabelle Johansson Karen Sliwa Eva Lonn | 2024/1/11 |
A novel, small-volume subcutaneous furosemide formulation delivered by an abdominal patch infusor device in patients with heart failure: results of two phase I studies | European Heart Journal-Cardiovascular Pharmacotherapy | Joanna Osmanska Katriona Brooksbank Kieran F Docherty Stacy Robertson Kirsty Wetherall | 2024/1 |
Impact of vasodilators on diuretic response in patients with congestive heart failure: A mechanistic trial of cimlanod (BMS‐986231) | European Journal of Heart Failure | Pierpaolo Pellicori John GF Cleland Maria Borentain Jorg Taubel Fraser J Graham | 2024/1 |
Independent prognostic importance of blood urea nitrogen to creatinine ratio in heart failure | European journal of heart failure | Paolo Tolomeo Jawad H Butt Toru Kondo Gianluca Campo Akshay S Desai | 2024/2 |
Efficacy and safety of dapagliflozin in patients with chronic kidney disease across the spectrum of frailty | The Journals of Gerontology: Series A | Priya Vart Jawad H Butt Niels Jongs Meir Schechter Glenn M Chertow | 2024/2/1 |
Dapagliflozin and diuretic utilization in heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial | European heart journal | Safia Chatur Muthiah Vaduganathan Brian Claggett Orly Vardeny Akshay S Desai | 2023/8/14 |
Dapagliflozin in black and white patients with heart failure across the ejection fraction spectrum | Heart Failure | Jawad H Butt Kieran F Docherty Brian L Claggett Akshay S Desai James C Fang | 2023/4/1 |
Initiation of SGLT2 inhibitors and GLP-1 receptor agonists according to level of frailty in people with type 2 diabetes and cardiovascular disease in Denmark: a cross-sectional … | The Lancet Healthy Longevity | Mariam Elmegaard Malik Jawad Haider Butt Jarl Emanuel Strange Alexander Christian Falkentoft Jesper Jensen | 2023/10/1 |
Dapagliflozin and physical and social activity limitations in heart failure with reduced ejection fraction | Heart Failure | Jawad H Butt Kieran F Docherty Mikhail N Kosiborod Silvio E Inzucchi Lars Køber | 2023/10/1 |
Carbohydrate antigen 125 in HFrEF and the effect of dapagliflozin: findings from DAPA-HF | Journal of the American College of Cardiology | Kieran F Docherty Kirsty McDowell Paul Welsh Joanna Osmanska Inder Anand | 2023/5/2 |
Impact of comorbidities on health status measured using the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with reduced and preserved ejection fraction | European Journal of Heart Failure | Mingming Yang Toru Kondo Carly Adamson Jawad H Butt William T Abraham | 2023/9 |
Heart failure, chronic obstructive pulmonary disease and efficacy and safety of dapagliflozin in heart failure with mildly reduced or preserved ejection fraction: Insights from … | European Journal of Heart Failure | Jawad H Butt Henri Lu Toru Kondo Erasmus Bachus Rudolf A de Boer | 2023/11 |
Treatment With Sacubitril/valsartan Vs Valsartan Reduces New Loop Diuretic Use In PARAGON-HF | Journal of Cardiac Failure | Safia Chatur Muthiah Vaduganathan Brian Claggett Orly Vardeny Karola Jering | 2023/4/1 |
Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis | Nephrology Dialysis Transplantation | Phil McEwan Rebecca Boyce Juan Jose Garcia Sanchez C David Sjöström Bergur Stefansson | 2023/5 |
Efficacy of implantable haemodynamic monitoring in heart failure across ranges of ejection fraction: a systematic review and meta-analysis | James P Curtain Matthew MY Lee John JV McMurray Roy S Gardner Mark C Petrie | 2023/6/1 | |
Impact of COVID‐19 in patients with heart failure with mildly reduced or preserved ejection fraction enrolled in the DELIVER trial | European Journal of Heart Failure | Ankeet S Bhatt Mikhail N Kosiborod Brian L Claggett Zi Michael Miao Muthiah Vaduganathan | 2023/12 |
Effect of dapagliflozin on total heart failure events in patients with heart failure with mildly reduced or preserved ejection fraction: a prespecified analysis of the DELIVER … | JAMA cardiology | Pardeep S Jhund Brian L Claggett Atefeh Talebi Jawad H Butt Samvel B Gasparyan | 2023/6/1 |
Physical Frailty and Use of Guideline‐Recommended Drugs in Patients With Heart Failure and Reduced Ejection Fraction | Journal of the American Heart Association | Toru Kondo Takuji Adachi Kiyonori Kobayashi Takahiro Okumura Hideo Izawa | 2023/6/20 |
Dapagliflozin in patients with heart failure and deterioration in renal function | Journal of the American College of Cardiology | Safia Chatur Muthiah Vaduganathan Brian L Claggett Finnian R Mc Causland Akshay S Desai | 2023/11/7 |
Predicting stroke in heart failure and preserved ejection fraction without atrial fibrillation | Circulation: Heart Failure | Toru Kondo Karola S Jering Pardeep S Jhund Inder S Anand Akshay S Desai | 2023/7 |
Co-Authors
